The concept of bioMEMs becomes as a result of expanding the interaction of microsystems to biological systems. This concept includes biosensors, micro-actuators, lab-on-a-chip devices (LoC), micro total analysis systems (µTAS), etc. Currently the development of bioMEMs devices in biotechnology is one of the most promising disciplines for the future.

This technology presents important advantages, as miniaturization, fast response, easy integration, translatable and scalable. Is especially relevant when apply in industrial environments, commercial devices, healthcare environments, food industry, etc. Especially the healthcare market is demanding more autonomous and reliable methods for Point of Care systems. Biomedical microsystems include a large class of diagnostic systems for blood or other body fluid analysis and drug delivery systems capable of supplying precise quantities of a drug at the right time and as close to the treatment site as possible. As such, the microfabricated devices utilising microfluidic subsystems are expected to provide a next generation of inexpensive tools for diagnostics.

But bioMEMs can also benefit other important industrial sectors like environmental management or the food industry. The rapid advances in nano and micro sciences allow the development of new tools to monitor processes and generate prophylactic strategies based on in situ measurements. Ad hoc solutions can easily integrate a number of this microsystems providing important information for improving efficiency and safety.

Currently CEIT is using these technologies to successfully create advanced solutions for real problems with strategic collaborators.

  • Microbiology Service from the University Clinic of Navarra
  • Otolaringology Service from the University Clinic of Navarra
  • Science Faculty from the University of Navarra
  • Applied Medical Research Centre from the University of Navarra
  • The leading Cochlear implant company, Cochlear

Technical Competences